Health Strategies Group - Pharmaceutical and Biotech Articles

	Managed Markets
	Account Management Advantage NEW
	Best Practices
	Cross-Category Access NEW
	Pharmacy Benefit Managers
	Strategic Accounts

	Specialty Biotech
	Managed Care Complete NEW
	Oncology Performance Edge NEW
	Specialty Pharmacy Management
	Specialty Sales Opportunity Assessment

	Sales Representatives & Managers
	PharmaSME
	SFE Library
	Strategic Selling Outlook

	Institutional Markets
	HospitalSFE
	Institutional Provider Systems

	Government as Payer
	Managed Medicare Rx
	Medicaid Rx Payers

	Managed Markets Consulting


Account Management Advantage is a new market intelligence service from Health Strategies Group that helps pharmaceutical and biotech professionals optimize access with managed care customers by: Identifying effective account management strategies, resources, and practices Measuring company-specific performance, and Providing practical recommendations to improve View our 2010 Account Management Advantage research schedule. View our 2011 Account Management Advantage research schedule. Click the symbol to expand the headings and view descriptions of our research publications. Access to full publications is by subscription. Nonsubscribers may view summaries of research (available for some publications).	Subscribing Companies Receive Inquiry privileges with our research leaders On-site briefings and workshops with our project experts Opportunities for input into the research Four syndicated research studies in both hard copy and electronic format; plus quarterly updates Access to our website; customized for your organization Contact Account Management Advantage
Account Management Advantage Publications
2011 Total Account Approach and Performance Coming March 2011 This research describes how manufacturers perform at accessing and strengthening relationships across three key stakeholders—contracting decision makers, clinical decision makers, and senior executive decision makers. Manufacturer Relationships with Contracting Decision Makers - 2011 Coming July 2011 An analysis of key components of the business relationships between manufacturers and formulary/contracting decision makers. Manufacturer Relationships with Senior Executive Decision Makers Coming September 2011 An analysis of manufacturer best practices in identifying appropriate targets, designing relevant discussion topics, and gaining long-term business relationships with senior executives of health plans and PBMs. Manufacturer Relationships with Clinical Decision Makers - 2011 Coming December 2011 An analysis of the relationship skills and resources needed to engage clinical decision makers within health plan and PBM customers. 2010 Total Account Approach February 2010 In this research we describe how manufacturers can improve their relationships with three key stakeholders—formulary and contracting decision makers, clinical decision makers, and the C-suite level. View Research Summary Manufacturer Relationships with Contracting Decision Makers June 2010 An analysis of key components of the business relationships between manufacturers and formulary/contracting decision makers. View Research Summary Manufacturer Relationships with Contracting Decision Makers: Relationship Summary June 2010 Manufacturer Performance Review: Abbott Manufacturer Performance Review: Abbott Diabetes Care Manufacturer Performance Review: Allergan Manufacturer Performance Review: Amgen Manufacturer Performance Review: Amylin Manufacturer Performance Review: AstraZeneca Manufacturer Performance Review: Bayer Diabetes Care Manufacturer Performance Review: Biogen Idec Manufacturer Performance Review: Boehringer Ingelheim Manufacturer Performance Review: Bristol-Myers Squibb Manufacturer Performance Review: Centocor Ortho Biotech Manufacturer Performance Review: Eli Lilly Manufacturer Performance Review: EMD Serono Manufacturer Performance Review: Endo Pharmaceuticals Manufacturer Performance Review: Forest Manufacturer Performance Review: Genentech Manufacturer Performance Review: GlaxoSmithKline Manufacturer Performance Review: Johnson & Johnson HCS Manufacturer Performance Review: LifeScan Manufacturer Performance Review: Merck Manufacturer Performance Review: Novartis Manufacturer Performance Review: Novo Nordisk Manufacturer Performance Review: Ortho-McNeil/Janssen Manufacturer Performance Review: Pfizer Manufacturer Performance Review: Roche Diabetes Care Manufacturer Performance Review: sanofi-aventis Manufacturer Performance Review: Takeda Manufacturer Performance Review: Teva Neuroscience Manufacturer Performance Review: UCB Pharma Opportunities in the C-Suite Coming September 2010 An analysis of the strategies, skills, and resources needed to access critical customers at the C-suite level. Manufacturer Relationships with Clinical Decision Makers Coming December 2010 An analysis of the relationship skills and resources needed to engage clinical decision makers within health plan and PBM customers.